PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10470864-3	1999	The results have shown that DP and AMP act additively with G-CSF to enhance spleen colony formation and thus the erythroid repopulation of the spleen.	Dipyridamole	28-30	colony stimulating factor 3 (granulocyte)	Mus musculus	59-64	
10470864-5	1999	The enhancement of hemopoiesis-stimulating effects of G-CSF by DP and AMP, which are low-priced and clinically available drugs, could improve the cost-effectiveness of the therapy with G-CSF.	Dipyridamole	63-65	colony stimulating factor 3 (granulocyte)	Mus musculus	54-59	
10470864-5	1999	The enhancement of hemopoiesis-stimulating effects of G-CSF by DP and AMP, which are low-priced and clinically available drugs, could improve the cost-effectiveness of the therapy with G-CSF.	Dipyridamole	63-65	colony stimulating factor 3 (granulocyte)	Mus musculus	185-190	
16925466-1	2007	Our previous studies have shown that the combined administration of drugs elevating extracellular adenosine, i.e. dipyridamole (DP) and adenosine monophosphate (AMP), enhances murine hematopoiesis and potentiates the action of granulocyte colony-stimulating factor (G-CSF).	Dipyridamole	114-126	colony stimulating factor 3 (granulocyte)	Mus musculus	227-264	
16925466-1	2007	Our previous studies have shown that the combined administration of drugs elevating extracellular adenosine, i.e. dipyridamole (DP) and adenosine monophosphate (AMP), enhances murine hematopoiesis and potentiates the action of granulocyte colony-stimulating factor (G-CSF).	Dipyridamole	114-126	colony stimulating factor 3 (granulocyte)	Mus musculus	266-271	
16925466-7	2007	Our results show that the effects of DP+AMP are indirect, mediated through the induction of some cytokine(s) and/or growth factor(s) and that extracellular adenosine can act in cooperation with G-CSF.	Dipyridamole	37-39	colony stimulating factor 3 (granulocyte)	Mus musculus	194-199	
7579335-6	1995	It was shown that the effects of G-CSF, ie, increases in peripheral blood neutrophils, granulocyte-macrophage progenitor cells (GM-CFC), and morphologically determined granulocytic cells in femoral marrow and a decrease in the marrow erythroid cells, can be enhanced by the combination of dipyridamole plus AMP administered 30 minutes before G-CSF.	Dipyridamole	289-301	colony stimulating factor 3 (granulocyte)	Mus musculus	33-38	
7579335-7	1995	Furthermore, it was ascertained that the stimulatory action of dipyridamole plus AMP was expressed particularly at lower doses of G-CSF (1.5, 3, and 4.5 micrograms/d).	Dipyridamole	63-75	colony stimulating factor 3 (granulocyte)	Mus musculus	130-135	
7579335-9	1995	When combining dipyridamole, AMP, and 3 micrograms of G-CSF, peripheral neutrophils increased approximately 3.9- to 4.5-fold compared with an approximate 2.2-fold increase induced by G-CSF alone.	Dipyridamole	15-27	colony stimulating factor 3 (granulocyte)	Mus musculus	183-188